{"entity":{"type":"insider","cik":"0001367079","url":"/insider/0001367079","json_url":"/insider/0001367079.json","name":"Schutz James J","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":28,"n_filings":16,"first":"2007-12-07","last":"2018-03-08","span_basis":"filed_date"},"name_variants":[{"name":"Schutz James J","source":"filing","n_filings":16,"first_seen":"2007-12-07","last_seen":"2018-03-08"}],"transactions":[{"id":6599948,"accession":"0001683168-18-000628","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001683168-18-000628","line_url":"/filing/0001683168-18-000628#line-1","is_derivative":false,"issuer_cik":"0001367079","issuer_name":"Sonoma Pharmaceuticals, Inc.","issuer_ticker":"SNOA","issuer_name_source":null,"issuer_url":"/issuer/0001367079","owner_cik":"0001367079","owner_name":"Schutz James J","owner_display_name":"Schutz James J","owner_url":"/insider/0001367079","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock, $0.0001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2473.0,"shares_display":"2,473","price_per_share":3.99,"price_display":"3.99","price_state":"stated","total_value":9867.27,"total_display":"9,867.27","total_whole":"9,867","shares_owned_after":35858.0,"shares_owned_after_display":"35,858","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-03-08","filed_date":"2018-03-08","scope":"insider"},{"id":4793583,"accession":"0001683168-17-003218","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001683168-17-003218","line_url":"/filing/0001683168-17-003218#line-1","is_derivative":false,"issuer_cik":"0001367079","issuer_name":"Sonoma Pharmaceuticals, Inc.","issuer_ticker":"SNOA","issuer_name_source":null,"issuer_url":"/issuer/0001367079","owner_cik":"0001367079","owner_name":"Schutz James J","owner_display_name":"Schutz James J","owner_url":"/insider/0001367079","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock, $0.0001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":345.0,"shares_display":"345","price_per_share":4.95,"price_display":"4.95","price_state":"stated","total_value":1707.75,"total_display":"1,707.75","total_whole":"1,708","shares_owned_after":16174.0,"shares_owned_after_display":"16,174","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-11-30","filed_date":"2017-12-04","scope":"insider"},{"id":5028589,"accession":"0001683168-17-003172","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001683168-17-003172","line_url":"/filing/0001683168-17-003172#line-1","is_derivative":false,"issuer_cik":"0001367079","issuer_name":"Sonoma Pharmaceuticals, Inc.","issuer_ticker":"SNOA","issuer_name_source":null,"issuer_url":"/issuer/0001367079","owner_cik":"0001367079","owner_name":"Schutz James J","owner_display_name":"Schutz James J","owner_url":"/insider/0001367079","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock, $0.0001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":400.0,"shares_display":"400","price_per_share":5.03,"price_display":"5.03","price_state":"stated","total_value":2012.0,"total_display":"2,012.00","total_whole":"2,012","shares_owned_after":15829.0,"shares_owned_after_display":"15,829","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-11-29","filed_date":"2017-11-29","scope":"insider"},{"id":5232777,"accession":"0001683168-17-003155","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001683168-17-003155","line_url":"/filing/0001683168-17-003155#line-1","is_derivative":false,"issuer_cik":"0001367079","issuer_name":"Sonoma Pharmaceuticals, Inc.","issuer_ticker":"SNOA","issuer_name_source":null,"issuer_url":"/issuer/0001367079","owner_cik":"0001367079","owner_name":"Schutz James J","owner_display_name":"Schutz James J","owner_url":"/insider/0001367079","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock, $0.0001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":254.0,"shares_display":"254","price_per_share":5.05,"price_display":"5.05","price_state":"stated","total_value":1282.7,"total_display":"1,282.70","total_whole":"1,283","shares_owned_after":15429.0,"shares_owned_after_display":"15,429","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-11-24","filed_date":"2017-11-27","scope":"insider"},{"id":4264848,"accession":"0001683168-17-002034","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001683168-17-002034","line_url":"/filing/0001683168-17-002034#line-1","is_derivative":false,"issuer_cik":"0001367079","issuer_name":"Sonoma Pharmaceuticals, Inc.","issuer_ticker":"SNOA","issuer_name_source":null,"issuer_url":"/issuer/0001367079","owner_cik":"0001367079","owner_name":"Schutz James J","owner_display_name":"Schutz James J","owner_url":"/insider/0001367079","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock, $0.0001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":929.0,"shares_display":"929","price_per_share":5.4569,"price_display":"5.46","price_state":"stated","total_value":5069.4601,"total_display":"5,069.46","total_whole":"5,069","shares_owned_after":15175.0,"shares_owned_after_display":"15,175","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-08-10","filed_date":"2017-08-10","scope":"insider"},{"id":4912652,"accession":"0001683168-17-000511","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001683168-17-000511","line_url":"/filing/0001683168-17-000511","is_derivative":false,"issuer_cik":"0001367079","issuer_name":"Sonoma Pharmaceuticals, Inc.","issuer_ticker":"SNOA","issuer_name_source":null,"issuer_url":"/issuer/0001367079","owner_cik":"0001367079","owner_name":"Schutz James J","owner_display_name":"Schutz James J","owner_url":"/insider/0001367079","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock, par value $0.0001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":800.0,"shares_display":"800","price_per_share":6.7761,"price_display":"6.78","price_state":"stated","total_value":5420.88,"total_display":"5,420.88","total_whole":"5,421","shares_owned_after":11736.0,"shares_owned_after_display":"11,736","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-03-03","filed_date":"2017-03-07","scope":"insider","n_lines":2},{"id":2691922,"accession":"0001683168-16-000886","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001683168-16-000886","line_url":"/filing/0001683168-16-000886#line-1","is_derivative":false,"issuer_cik":"0001367079","issuer_name":"Sonoma Pharmaceuticals, Inc.","issuer_ticker":"SNOA","issuer_name_source":null,"issuer_url":"/issuer/0001367079","owner_cik":"0001367079","owner_name":"Schutz James J","owner_display_name":"Schutz James J","owner_url":"/insider/0001367079","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":4.88,"price_display":"4.88","price_state":"stated","total_value":4880.0,"total_display":"4,880.00","total_whole":"4,880","shares_owned_after":11040.0,"shares_owned_after_display":"11,040","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-12-08","filed_date":"2016-12-08","scope":"insider"},{"id":2163835,"accession":"0001019687-16-007285","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001019687-16-007285","line_url":"/filing/0001019687-16-007285#line-1","is_derivative":false,"issuer_cik":"0001367079","issuer_name":"Oculus Innovative Sciences, Inc.","issuer_ticker":"OCLS","issuer_name_source":null,"issuer_url":"/issuer/0001367079","owner_cik":"0001367079","owner_name":"Schutz James J","owner_display_name":"Schutz James J","owner_url":"/insider/0001367079","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1328.0,"shares_display":"1,328","price_per_share":3.6639,"price_display":"3.66","price_state":"stated","total_value":4865.6592,"total_display":"4,865.66","total_whole":"4,866","shares_owned_after":6505.0,"shares_owned_after_display":"6,505","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-08-15","filed_date":"2016-08-16","scope":"insider"},{"id":2945138,"accession":"0001019687-16-005303","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001019687-16-005303","line_url":"/filing/0001019687-16-005303#line-1","is_derivative":false,"issuer_cik":"0001367079","issuer_name":"Oculus Innovative Sciences, Inc.","issuer_ticker":"OCLS","issuer_name_source":null,"issuer_url":"/issuer/0001367079","owner_cik":"0001367079","owner_name":"Schutz James J","owner_display_name":"Schutz James J","owner_url":"/insider/0001367079","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":0.9999,"price_display":"1.00","price_state":"stated","total_value":4999.5,"total_display":"4,999.50","total_whole":"5,000","shares_owned_after":25885.0,"shares_owned_after_display":"25,885","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-02-25","filed_date":"2016-02-29","scope":"insider"},{"id":6663095,"accession":"0001019687-14-004341","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001019687-14-004341","line_url":"/filing/0001019687-14-004341#line-1","is_derivative":false,"issuer_cik":"0001367079","issuer_name":"Oculus Innovative Sciences, Inc.","issuer_ticker":"OCLS","issuer_name_source":null,"issuer_url":"/issuer/0001367079","owner_cik":"0001367079","owner_name":"Schutz James J","owner_display_name":"Schutz James J","owner_url":"/insider/0001367079","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6285.0,"shares_display":"6,285","price_per_share":1.78,"price_display":"1.78","price_state":"stated","total_value":11187.3,"total_display":"11,187.30","total_whole":"11,187","shares_owned_after":20885.0,"shares_owned_after_display":"20,885","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-11-17","filed_date":"2014-11-17","scope":"insider"},{"id":4218974,"accession":"0001019687-13-003254","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001019687-13-003254","line_url":"/filing/0001019687-13-003254#line-1","is_derivative":false,"issuer_cik":"0001367079","issuer_name":"Oculus Innovative Sciences, Inc.","issuer_ticker":"OCLS","issuer_name_source":null,"issuer_url":"/issuer/0001367079","owner_cik":"0001367079","owner_name":"Schutz James J","owner_display_name":"Schutz James J","owner_url":"/insider/0001367079","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5100.0,"shares_display":"5,100","price_per_share":2.35,"price_display":"2.35","price_state":"stated","total_value":11985.0,"total_display":"11,985.00","total_whole":"11,985","shares_owned_after":14600.0,"shares_owned_after_display":"14,600","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-08-16","filed_date":"2013-08-19","scope":"insider"},{"id":3408431,"accession":"0001019687-12-003929","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001019687-12-003929","line_url":"/filing/0001019687-12-003929","is_derivative":false,"issuer_cik":"0001367079","issuer_name":"Oculus Innovative Sciences, Inc.","issuer_ticker":"OCLS","issuer_name_source":null,"issuer_url":"/issuer/0001367079","owner_cik":"0001367079","owner_name":"Schutz James J","owner_display_name":"Schutz James J","owner_url":"/insider/0001367079","role":"Director, Officer (Chief Operating Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":13000.0,"shares_display":"13,000","price_per_share":0.7984615384615384,"price_display":"0.80","price_state":"stated","total_value":10380.0,"total_display":"10,380.00","total_whole":"10,380","shares_owned_after":65000.0,"shares_owned_after_display":"65,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-11-09","filed_date":"2012-11-09","scope":"insider","n_lines":4},{"id":7681283,"accession":"0001144204-10-042275","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001144204-10-042275","line_url":"/filing/0001144204-10-042275","is_derivative":false,"issuer_cik":"0001367079","issuer_name":"Oculus Innovative Sciences, Inc.","issuer_ticker":"OCLS","issuer_name_source":null,"issuer_url":"/issuer/0001367079","owner_cik":"0001367079","owner_name":"Schutz James J","owner_display_name":"Schutz James J","owner_url":"/insider/0001367079","role":"Director, Officer (Chief Operating Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":18500.0,"shares_display":"18,500","price_per_share":1.887881081081081,"price_display":"1.89","price_state":"stated","total_value":34925.8,"total_display":"34,925.80","total_whole":"34,926","shares_owned_after":53500.0,"shares_owned_after_display":"53,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-08-09","filed_date":"2010-08-09","scope":"insider","n_lines":2},{"id":5591391,"accession":"0001209191-09-056250","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-09-056250","line_url":"/filing/0001209191-09-056250","is_derivative":false,"issuer_cik":"0001367079","issuer_name":"Oculus Innovative Sciences, Inc.","issuer_ticker":"OCLS","issuer_name_source":null,"issuer_url":"/issuer/0001367079","owner_cik":"0001367079","owner_name":"Schutz James J","owner_display_name":"Schutz James J","owner_url":"/insider/0001367079","role":"Director, Officer (Chief Operating Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":1.790975,"price_display":"1.79","price_state":"stated","total_value":35819.5,"total_display":"35,819.50","total_whole":"35,820","shares_owned_after":29600.0,"shares_owned_after_display":"29,600","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-12-09","filed_date":"2009-12-09","scope":"insider","n_lines":4},{"id":5967192,"accession":"0001209191-09-040408","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-09-040408","line_url":"/filing/0001209191-09-040408","is_derivative":false,"issuer_cik":"0001367079","issuer_name":"Oculus Innovative Sciences, Inc.","issuer_ticker":"OCLS","issuer_name_source":null,"issuer_url":"/issuer/0001367079","owner_cik":"0001367079","owner_name":"Schutz James J","owner_display_name":"Schutz James J","owner_url":"/insider/0001367079","role":"Director, Officer (Vice President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Vice President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":2.039734,"price_display":"2.04","price_state":"stated","total_value":10198.67,"total_display":"10,198.67","total_whole":"10,199","shares_owned_after":15000.0,"shares_owned_after_display":"15,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-08-12","filed_date":"2009-08-13","scope":"insider","n_lines":4},{"id":7171141,"accession":"0001209191-07-068328","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-07-068328","line_url":"/filing/0001209191-07-068328","is_derivative":false,"issuer_cik":"0001367079","issuer_name":"Oculus Innovative Sciences, Inc.","issuer_ticker":"OCLS","issuer_name_source":null,"issuer_url":"/issuer/0001367079","owner_cik":"0001367079","owner_name":"Schutz James J","owner_display_name":"Schutz James J","owner_url":"/insider/0001367079","role":"Director, Officer (Vice President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Vice President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":4.644,"price_display":"4.64","price_state":"stated","total_value":46440.0,"total_display":"46,440.00","total_whole":"46,440","shares_owned_after":null,"shares_owned_after_display":null,"ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-12-07","filed_date":"2007-12-07","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":28,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":28,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":28},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001367083","name":"Sonoma Pharmaceuticals, Inc.","url":"/issuer/0001367083","role":"Director, Officer (Chief Executive Officer)","n_filings":16,"first_seen":"2007-12-07","last_seen":"2018-03-08"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001367079","retrieved_at":"2026-08-25T02:31:44+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}